English | Español
Patient Daily Report | May 25, 2023

FDA approves Opvee, prescription nasal spray opioid reversal agent
Patient Daily Report | May 24, 2023

Survey reveals high levels of financial stress among American workforce; 64% of workers living paycheck to paycheck
Patient Daily Report | May 23, 2023

Doctor says innovative technology will 'provide the Type 1 diabetes community with additional options and flexibilities for diabetes management'
Patient Daily | May 18, 2023

Zynex Announces Proposed $50 Million Offering of Convertible Senior Notes
Patient Daily | May 18, 2023

Zynex Announces Proposed Secondary Public Offering of Common Stock
Patient Daily | May 18, 2023

Zynex Announces Update Regarding Previously Announced Offerings
Patient Daily | May 18, 2023

Zynex Prices Upsized $52.5 Million Convertible Senior Notes Offering
Patient Daily | May 18, 2023

Sotera Health Reports First-Quarter 2023 Results

Trending
+ Technology/Innovation
Patient Daily | May 8, 2025

Medfluence attends 2025 Annual Clinical Assembly as only strategic marketing firm
+ Technology/Innovation
Patient Daily | May 7, 2025

OTO Forum 2025 highlights innovation in ENT
+ Pharmaceuticals
Patient Daily | May 8, 2025

Pacific Research Institute CEO: Hospitals are leveraging 340B's 'perverse incentives to enrich themselves'
+ Pharmaceuticals
Patient Daily | May 8, 2025

National Library of Medicine says compounded drugs like GLP-1 offer tailored alternatives to FDA-approved treatments